YU104091A - Dialkoksi-piridinil-benzimidazolovi derivati 1 postupak za njihovo dobijanje - Google Patents
Dialkoksi-piridinil-benzimidazolovi derivati 1 postupak za njihovo dobijanjeInfo
- Publication number
- YU104091A YU104091A YU104091A YU104091A YU104091A YU 104091 A YU104091 A YU 104091A YU 104091 A YU104091 A YU 104091A YU 104091 A YU104091 A YU 104091A YU 104091 A YU104091 A YU 104091A
- Authority
- YU
- Yugoslavia
- Prior art keywords
- carbon atoms
- dialcoxy
- pyridinyl
- benzimidazole derivatives
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
DIALKOKSI-PIRIDINIL-BENZIMIDAZOLOVI DERIVATI 1 POSTUPAK ZA NJIHOVO DOBIJANJE, nova jedinjenja formule I: i njihove fiziološke soli, pri čemu su u formuli: R1 i R2, koji su različiti, svaki H, alkil koji sadrži 1-4 ugljenikova atoma ili -C(O)-R5, pri čemu se jedan od R1 i R2 uvek bira od grupe -C(O)-R5; gde je: R5 alkil koji sadrži 1-4 atoma ugljenika ili alkoksi koji sadrži 1-4 atoma ugljenika, R3 i R4 su isti ili različiti i izabrani su od i R4 formiraju zajednički sa susednim atomima kiseonika spojenim za piridinski prsten i sa ugljenikovim atomima u piridinskom prstenu neki prsten u kojem je deo koji čine R4 i R5 -CH2CH2CH2-, -CH2CH2-ili -CH2-; kao i intermedijeri, farmaceutski preparati koji sadrže jedinjenja kao aktivan sastojak i korišćenje jedinjenja u medicini.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9002206A SE9002206D0 (sv) | 1990-06-20 | 1990-06-20 | New compounds |
SE9002207A SE9002207D0 (sv) | 1990-06-20 | 1990-06-20 | New compounds i |
Publications (1)
Publication Number | Publication Date |
---|---|
YU104091A true YU104091A (sh) | 1994-01-20 |
Family
ID=26660803
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
YU104091A YU104091A (sh) | 1990-06-20 | 1991-06-12 | Dialkoksi-piridinil-benzimidazolovi derivati 1 postupak za njihovo dobijanje |
Country Status (29)
Country | Link |
---|---|
US (1) | US5430042A (sh) |
EP (1) | EP0593463B1 (sh) |
JP (1) | JP3049367B2 (sh) |
CN (1) | CN1058213A (sh) |
AP (1) | AP253A (sh) |
AT (1) | ATE184602T1 (sh) |
AU (1) | AU649456B2 (sh) |
BG (1) | BG97198A (sh) |
CA (1) | CA2083606C (sh) |
CZ (1) | CZ279434B6 (sh) |
DE (1) | DE69131627T2 (sh) |
EG (1) | EG19752A (sh) |
ES (1) | ES2140391T3 (sh) |
FI (1) | FI925767A0 (sh) |
HU (1) | HUT62882A (sh) |
IE (1) | IE912026A1 (sh) |
IL (1) | IL98472A (sh) |
IS (1) | IS3720A7 (sh) |
LV (1) | LV10269B (sh) |
MA (1) | MA22198A1 (sh) |
NO (1) | NO924650D0 (sh) |
NZ (1) | NZ238545A (sh) |
OA (1) | OA09683A (sh) |
PL (2) | PL166209B1 (sh) |
PT (1) | PT98036A (sh) |
RO (1) | RO110497B1 (sh) |
TN (1) | TNSN91050A1 (sh) |
WO (1) | WO1991019712A1 (sh) |
YU (1) | YU104091A (sh) |
Families Citing this family (63)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE9103776D0 (sv) * | 1991-12-19 | 1991-12-19 | Astra Ab | New compounds |
TNSN95062A1 (fr) * | 1994-05-27 | 1996-02-06 | Astra Ab | Nouveaux derives dialkoxy-pyridinyle-benzimidazole |
DK0723436T3 (da) * | 1994-07-08 | 2001-11-26 | Astrazeneca Ab | Tabletteret flerenhedsdoseringsform |
SE9402431D0 (sv) * | 1994-07-08 | 1994-07-08 | Astra Ab | New tablet formulation |
GB9423970D0 (en) * | 1994-11-28 | 1995-01-11 | Astra Ab | Oxidation |
SE9500422D0 (sv) * | 1995-02-06 | 1995-02-06 | Astra Ab | New oral pharmaceutical dosage forms |
SE9500478D0 (sv) * | 1995-02-09 | 1995-02-09 | Astra Ab | New pharmaceutical formulation and process |
US5545661A (en) * | 1995-05-16 | 1996-08-13 | Eli Lilly And Company | Methods for inhibiting bone loss with bis-pyrone oxovanadium compounds |
US6645988B2 (en) * | 1996-01-04 | 2003-11-11 | Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and method of using same |
US5840737A (en) | 1996-01-04 | 1998-11-24 | The Curators Of The University Of Missouri | Omeprazole solution and method for using same |
US6489346B1 (en) | 1996-01-04 | 2002-12-03 | The Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and method of using same |
US6699885B2 (en) * | 1996-01-04 | 2004-03-02 | The Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and methods of using same |
SE9600070D0 (sv) | 1996-01-08 | 1996-01-08 | Astra Ab | New oral pharmaceutical dosage forms |
US6051570A (en) * | 1997-05-30 | 2000-04-18 | Dr. Reddy's Research Foundation | Benzimidazole derivatives as antiulcer agents, process for their preparation and pharmaceutical compositions containing them |
CA2295817C (en) * | 1997-07-11 | 2008-02-12 | Eisai Co., Ltd. | Method for producing pyridine compound |
GB9805558D0 (en) * | 1998-03-17 | 1998-05-13 | Knoll Ag | Chemical process` |
NZ510180A (en) * | 1998-08-10 | 2002-11-26 | Univ California | Prodrugs of the pyridyl-methylsulphonyl-benzimidazole type proton pump inhibitors |
US6093734A (en) * | 1998-08-10 | 2000-07-25 | Partnership Of Michael E. Garst, George Sachs, And Jai Moo Shin | Prodrugs of proton pump inhibitors |
SE0101379D0 (sv) | 2001-04-18 | 2001-04-18 | Diabact Ab | Komposition som hämmar utsöndring av magsyra |
US8206741B2 (en) | 2001-06-01 | 2012-06-26 | Pozen Inc. | Pharmaceutical compositions for the coordinated delivery of NSAIDs |
EP1469839A2 (en) * | 2002-01-25 | 2004-10-27 | Santarus, Inc. | Transmucosal delivery of proton pump inhibitors |
US7906145B2 (en) | 2002-04-09 | 2011-03-15 | Flamel Technologies | Oral pharmaceutical formulation in the form of aqueous suspension for modified release of active principle(s) |
JP4463103B2 (ja) * | 2002-07-19 | 2010-05-12 | ウィンストン・ファーマシューティカルズ・リミテッド・ライアビリティ・カンパニー | ベンズイミダゾール誘導体およびプロトンポンプ阻害剤のプロドラッグとしてのその使用 |
SE0203065D0 (sv) | 2002-10-16 | 2002-10-16 | Diabact Ab | Gastric acid secretion inhibiting composition |
JP2006518751A (ja) * | 2003-02-20 | 2006-08-17 | サンタラス インコーポレイティッド | 胃酸の急速かつ持続的な抑制のための新規製剤、オメプラゾール制酸剤複合体−即時放出物 |
EP2112920B1 (en) | 2003-06-26 | 2018-07-25 | Intellipharmaceutics Corp. | Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient |
US8993599B2 (en) * | 2003-07-18 | 2015-03-31 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
TWI337877B (en) * | 2003-07-18 | 2011-03-01 | Santarus Inc | Pharmaceutical formulation and method for treating acid-caused gastrointestinal disorders |
AU2004314693B2 (en) | 2003-09-26 | 2011-04-07 | Alza Corporation | Drug coating providing high drug loading and methods for providing the same |
US20050075371A1 (en) * | 2003-10-03 | 2005-04-07 | Allergan, Inc. | Methods and compositions for the oral administration of prodrugs of proton pump inhibitors |
US20060241037A1 (en) * | 2003-10-03 | 2006-10-26 | Allergan Inc. | Compositions comprising trefoil factor family peptides and/or mucoadhesives and proton pump ihhibitor prodrugs |
BRPI0507837A (pt) * | 2004-02-18 | 2007-07-10 | Allergan Inc | métodos e composições para a administração intravenosa de compostos relacionados a inibidores de bomba de prótons |
WO2005082337A2 (en) * | 2004-02-18 | 2005-09-09 | Allergan, Inc. | Compositions comprising prodrugs of proton pump inhibitors |
TW200606163A (en) * | 2004-04-22 | 2006-02-16 | Eisai Co Ltd | Imidazopyridine compound |
US8815916B2 (en) * | 2004-05-25 | 2014-08-26 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
US8906940B2 (en) * | 2004-05-25 | 2014-12-09 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
US8394409B2 (en) | 2004-07-01 | 2013-03-12 | Intellipharmaceutics Corp. | Controlled extended drug release technology |
WO2006013960A1 (ja) * | 2004-08-06 | 2006-02-09 | Eisai R & D Management Co., Ltd. | ベンズイミダゾール誘導体とアミンとの塩およびその製造方法 |
US10624858B2 (en) | 2004-08-23 | 2020-04-21 | Intellipharmaceutics Corp | Controlled release composition using transition coating, and method of preparing same |
US8541026B2 (en) | 2004-09-24 | 2013-09-24 | Abbvie Inc. | Sustained release formulations of opioid and nonopioid analgesics |
US20070015782A1 (en) | 2005-04-15 | 2007-01-18 | Eisai Co., Ltd. | Benzimidazole compound |
US9040564B2 (en) | 2005-04-28 | 2015-05-26 | Eisai R&D Management Co., Ltd. | Stabilized composition |
US7981908B2 (en) | 2005-05-11 | 2011-07-19 | Vecta, Ltd. | Compositions and methods for inhibiting gastric acid secretion |
US7803817B2 (en) | 2005-05-11 | 2010-09-28 | Vecta, Ltd. | Composition and methods for inhibiting gastric acid secretion |
US10064828B1 (en) | 2005-12-23 | 2018-09-04 | Intellipharmaceutics Corp. | Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems |
CA2648280C (en) | 2006-04-03 | 2014-03-11 | Isa Odidi | Controlled release delivery device comprising an organosol coat |
WO2007122686A1 (ja) * | 2006-04-14 | 2007-11-01 | Eisai R & D Management Co., Ltd. | ベンズイミダゾール化合物 |
US10960077B2 (en) | 2006-05-12 | 2021-03-30 | Intellipharmaceutics Corp. | Abuse and alcohol resistant drug composition |
RU2467747C2 (ru) | 2006-07-25 | 2012-11-27 | Векта Лтд. | Композиции и способы для ингибирования секреции желудочной кислоты с использованием производных малых дикарбоновых кислот в сочетании с ppi |
WO2008036201A1 (en) * | 2006-09-19 | 2008-03-27 | Alevium Pharmaceuticals, Inc. | Prodrugs of proton pump inhibitors including the 1h-imidazo[4,5-b] pyridine moiety |
US20090092658A1 (en) * | 2007-10-05 | 2009-04-09 | Santarus, Inc. | Novel formulations of proton pump inhibitors and methods of using these formulations |
JP2009196894A (ja) * | 2006-10-13 | 2009-09-03 | Eisai R & D Management Co Ltd | スルフィニルベンズイミダゾール化合物またはその塩の製造方法 |
US20110009624A9 (en) | 2006-10-13 | 2011-01-13 | Masato Ueda | Benzimidazole compounds having gastric acid secretion inhibitory action |
EP2486910A3 (en) | 2006-10-27 | 2012-08-22 | The Curators Of The University Of Missouri | Multi-chambered apparatus comprising a dispenser head |
US20080194307A1 (en) * | 2007-02-13 | 2008-08-14 | Jeff Sanger | Sports-based game of chance |
US8247440B2 (en) | 2008-02-20 | 2012-08-21 | Curators Of The University Of Missouri | Composition comprising omeprazole, lansoprazole and at least one buffering agent |
BRPI0918492A2 (pt) | 2008-09-09 | 2015-12-01 | Astrazeneca Ab | uso de naproxen, ou sal farmaceuticamente aceitável do mesmo, e esomeprazol, ou sal farmaceuticamente aceitável do mesmo |
SG176724A1 (en) | 2009-06-25 | 2012-01-30 | Astrazeneca Ab | Method for treating a patient at risk for developing an nsaid-associated ulcer |
WO2011080501A2 (en) | 2009-12-29 | 2011-07-07 | Orexo Ab | New pharmaceutical dosage form for the treatment of gastric acid-related disorders |
WO2011080500A2 (en) | 2009-12-29 | 2011-07-07 | Orexo Ab | New pharmaceutical dosage form for the treatment of gastric acid-related disorders |
WO2011080502A2 (en) | 2009-12-29 | 2011-07-07 | Orexo Ab | New pharmaceutical dosage form for the treatment of gastric acid-related disorders |
EP2601947A1 (en) | 2011-12-05 | 2013-06-12 | Abo Bakr Mohammed Ali Al-Mehdar | Fixed-dose combination for treatment of helicobacter pylori associated diseases |
US9539214B2 (en) | 2011-12-28 | 2017-01-10 | Pozen Inc. | Compositions and methods for delivery of omeprazole plus acetylsalicylic acid |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE7804231L (sv) * | 1978-04-14 | 1979-10-15 | Haessle Ab | Magsyrasekretionsmedel |
US4359465A (en) * | 1980-07-28 | 1982-11-16 | The Upjohn Company | Methods for treating gastrointestinal inflammation |
AU568441B2 (en) * | 1984-09-24 | 1987-12-24 | Upjohn Company, The | 2-(pyridylalkenesulfinyl) benzimidazole derivatives |
IL76839A (en) * | 1984-10-31 | 1988-08-31 | Byk Gulden Lomberg Chem Fab | Picoline derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same |
SE8500996D0 (sv) * | 1985-03-01 | 1985-03-01 | Haessle Ab | Method of treatment |
US4738975A (en) * | 1985-07-02 | 1988-04-19 | Takeda Chemical Industries, Ltd. | Pyridine derivatives, and use as anti-ulcer agents |
SE8505112D0 (sv) * | 1985-10-29 | 1985-10-29 | Haessle Ab | Novel pharmacological compounds |
NZ222495A (en) * | 1986-11-21 | 1991-04-26 | Haessle Ab | Benzimidazole derivatives and pharmaceutical compositions |
DE3722810A1 (de) * | 1987-07-10 | 1989-01-19 | Hoechst Ag | Substituierte benzimidazole, verfahren zu deren herstellung, diese enthaltende pharmazeutische zubereitungen und deren verwendung |
HU886738D0 (en) * | 1987-10-30 | 1990-02-28 | Haessle Ab | Process for the preparation of pharmaceutical compositions against osteoporosis containing 2-pyridinyl-methyl-(sulfinyl or thio)-benzimidazoles |
AU2817989A (en) * | 1987-12-11 | 1989-07-05 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Novel benzimidazole derivatives |
WO1989011479A1 (en) * | 1988-05-25 | 1989-11-30 | Byk Gulden Lomberg Chemische Fabrik Gmbh | New fluoralkoxy compounds |
SE8804628D0 (sv) * | 1988-12-22 | 1988-12-22 | Ab Haessle | New compounds |
US4965269A (en) * | 1989-12-20 | 1990-10-23 | Ab Hassle | Therapeutically active chloro substituted benzimidazoles |
-
1991
- 1991-06-11 JP JP3511436A patent/JP3049367B2/ja not_active Expired - Fee Related
- 1991-06-11 AU AU80617/91A patent/AU649456B2/en not_active Ceased
- 1991-06-11 EP EP91911618A patent/EP0593463B1/en not_active Expired - Lifetime
- 1991-06-11 CA CA002083606A patent/CA2083606C/en not_active Expired - Fee Related
- 1991-06-11 DE DE69131627T patent/DE69131627T2/de not_active Expired - Fee Related
- 1991-06-11 ES ES91911618T patent/ES2140391T3/es not_active Expired - Lifetime
- 1991-06-11 AT AT91911618T patent/ATE184602T1/de not_active IP Right Cessation
- 1991-06-11 HU HU924034A patent/HUT62882A/hu unknown
- 1991-06-11 PL PL91297294A patent/PL166209B1/pl unknown
- 1991-06-11 PL PL91297295A patent/PL165898B1/pl unknown
- 1991-06-11 RO RO92-01543A patent/RO110497B1/ro unknown
- 1991-06-11 WO PCT/SE1991/000416 patent/WO1991019712A1/en active IP Right Grant
- 1991-06-12 YU YU104091A patent/YU104091A/sh unknown
- 1991-06-12 IL IL9847291A patent/IL98472A/en not_active IP Right Cessation
- 1991-06-14 NZ NZ238545A patent/NZ238545A/xx unknown
- 1991-06-14 IE IE202691A patent/IE912026A1/en unknown
- 1991-06-18 EG EG38491A patent/EG19752A/xx active
- 1991-06-18 MA MA22461A patent/MA22198A1/fr unknown
- 1991-06-19 PT PT98036A patent/PT98036A/pt not_active Application Discontinuation
- 1991-06-19 TN TNTNSN91050A patent/TNSN91050A1/fr unknown
- 1991-06-19 AP APAP/P/1991/000286A patent/AP253A/en active
- 1991-06-20 US US07/718,188 patent/US5430042A/en not_active Expired - Lifetime
- 1991-06-20 CZ CS911893A patent/CZ279434B6/cs unknown
- 1991-06-20 IS IS3720A patent/IS3720A7/is unknown
- 1991-06-20 CN CN91105025A patent/CN1058213A/zh active Pending
-
1992
- 1992-11-27 OA OA60307A patent/OA09683A/en unknown
- 1992-12-02 NO NO924650A patent/NO924650D0/no unknown
- 1992-12-18 BG BG097198A patent/BG97198A/bg unknown
- 1992-12-18 FI FI925767A patent/FI925767A0/fi not_active Application Discontinuation
-
1993
- 1993-06-30 LV LVP-93-820A patent/LV10269B/en unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
YU104091A (sh) | Dialkoksi-piridinil-benzimidazolovi derivati 1 postupak za njihovo dobijanje | |
YU101091A (sh) | Heterociklična jedinjenja i njihovi derivati koji su modifikatori dejstva 5-hidroksitriptamina i postupak njihovog dobijanja | |
SE9002206D0 (sv) | New compounds | |
YU48105B (sh) | Derivati triazola i postupak za njihovo dobijanje | |
FI860089A0 (fi) | Naftalinderivat och foerfarande foer deras framstaellning. | |
YU21597A (sh) | Inhibitori metaloproteinaze, farmaceutski preparati koji ih sadrže i njihove farmaceutske primene i postupci i intermedijeri korisni za njihovo dobijanje | |
YU56192A (sh) | Heterociklični derivati | |
ES2071826T3 (es) | Compuestos de discodermolida, composiciones que contienen los mismos y procedimientos de preparacion y uso. | |
FR2667068B1 (fr) | Nouvelles amines alkyl heterocycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. | |
ES514267A0 (es) | "un procedimiento para la preparacion de derivados de pirrolidina". | |
DE69311118T2 (de) | Phosphono-arylethanolamin-verbindungen mit antihyperglykämischer und/oder antiobeser wirkung | |
SE8404554D0 (sv) | Mellanprodukter for framstellning av 2-substituerade trans-5-aryl-2,3,4,4a,9b-hexahydro-1h-pyrido(4,3-b)indoler | |
FR2576022B1 (fr) | Nouveaux derives de la pristinamycine ii b, leur preparation et les compositions pharmaceutiques qui les contiennent | |
AU4721985A (en) | Tricyclic or tetracyclic compounds, process for their preparation, and medicinal composition containing them | |
FR2612517B1 (fr) | Derives de benzoxazine, procedes de preparation de ces derives et compositions pharmaceutiques les contenant | |
ATE161837T1 (de) | Benzopyran derivat, seine darstellung und pharmazeutische zusammensetzung, welche dieses enthält | |
YU101692A (sh) | Supstituisani benzimidazoli i postupak za njihovo pravljenje | |
SE8903312L (sv) | New 2-carbonyl substituted n,n'-di-(trimethoxybenzol)piperazines, process for preparing the same and therapeutical compounds containing them | |
ES8702905A1 (es) | Un procedimiento para preparar derivados de alcanoles hete- ropoliciclicos | |
NZ241824A (en) | Platinum (ii) complexes of 4,5-bis(aminomethyl)-1,3- dioxolane derivatives; pharmaceutical compositions and 4,5-bis(aminomethyl and azidomethyl)-1,3-dioxolane derivatives | |
JO1672B1 (en) | Dialoxy-pyridinyl-benzimidazole derivatives and a way to prepare and use it in a pharmacy | |
YU237190A (sh) | Aktivni fluoro-supstituisani benzimidazoli i postupci za njihovo dobijanje | |
YU195591A (sh) | Derivati cefalosporina | |
SE8903313L (sv) | Nya 2-metoxikarbonyl-substituerade n,n'-di-(trimetoxibensoyl)-piperaziner, foerfarande foer framstaellning daerav och terapeutiska foereningar innehaallande dem | |
GR3008034T3 (sh) |